ArticleCellular & molecular immunology2026

Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation.

Felix I L ClanchyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.